InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Saik Andrew, Chief Financial Officer. Officer active across 3 companies, notably VYNE Therapeutics Inc.. Aggregated, 19 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €89k. History available since 28 May 2021. The latest transaction was filed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Saik Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
5,696 sharesCommon StockSEC:0001628280-26-045286:0
45,000 shares0Common StockSEC:0001628280-26-013531:0
5,134 shares@ US$11.8957.9% of flowCommon StockSEC:0001628280-26-009306:0
5,700 shares@ US$7.61100.0% of flowCommon StockSEC:0001655759-25-000109:0
59,600 shares0Common StockSEC:0001655759-25-000091:0
49,092 shares0Common StockSEC:0001655759-25-000027:0
61,409 shares0Common StockSEC:0001655759-24-000105:0
23,021 shares@ US$19.0079.2% of flowCommon StockSEC:0001104659-23-117093:0
908 shares@ US$10.808.6% of flowCommon StockSEC:0001104659-23-103508:0
908 shares@ US$11.741.9% of flowCommon StockSEC:0001104659-23-074233:0
909 shares@ US$14.192.3% of flowCommon StockSEC:0001104659-23-036043:0
14,700 shares0Common StockSEC:0001104659-23-008588:0
718 shares@ US$12.371.6% of flowCommon StockSEC:0001104659-23-000337:0
908 shares@ US$13.432.2% of flowCommon StockSEC:0001104659-22-129883:0
908 shares@ US$14.852.7% of flowCommon StockSEC:0001104659-22-102662:0
3,632 shares@ US$12.48100.0% of flowCommon StockSEC:0001104659-22-073886:0
10,300 shares0Common StockSEC:0001104659-22-009563:0
52,156 shares0Common StockSEC:0001104659-21-084279:0
3,017 shares@ US$3.3575100.0% of flowCommon StockSEC:0001209191-21-037193:0
19 of 19 declarations
About Saik Andrew
Saik Andrew is Chief Financial Officer and has 19 filings in total. In the 19 most recent sampled filings, the buy amount is EUR 0 and the sell amount is EUR 88788, over the period from 2021-06-02 to 2026-06-24. The main filings concern Intercept Pharmaceuticals, INC. and Arvinas, INC., with Attribution and sell transactions.
